Plus Therapeutics Inc (PSTV)
NASDAQ · Healthcare
Plus Therapeutics Inc Shareholder Equity 2009–2025
Plus Therapeutics Inc annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Plus Therapeutics Inc shareholder equity as of December 31, 2025: 4.0M, a 144.65% decrease year-over-year.
- Plus Therapeutics Inc shareholder equity for 2025 were 4.0M, a 144.65% decrease from 2024.
- Plus Therapeutics Inc shareholder equity for 2024 were -8.9M, a 563.87% increase from 2023.
- Plus Therapeutics Inc shareholder equity for 2023 were -1.3M, a 125.80% decrease from 2018.
- Plus Therapeutics Inc shareholder equity for 2018 were 5.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Plus Therapeutics Inc Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $-9 |
| 2023 | $-1 |
| 2018 | $5 |
| 2017 | $13 |
| 2016 | $11 |
| 2015 | $12 |
| 2014 | $-6 |
| 2013 | $3 |
| 2012 | $6 |
| 2011 | $10 |
| 2010 | $23 |
Plus Therapeutics Inc Shareholder Equity — FAQ
Plus Therapeutics Inc (PSTV) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PSTV's shareholder equity history?
The chart and table above show Plus Therapeutics Inc's shareholder equity by year and by quarter, including the growth rate.